SCHEMBL4937726

SCHEMBL4937726

ClCCN(CCCl)CCCCOc1cccc(Nc2c3ccccc3nc3c(OCCN(CCCl)CCCl)cccc23)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 7/20 0.46
AGER Q15109 1/20 0.38
TOP2A P11388 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
TOP2B Q02880 1/20 0.38
HTR1B P28222 1/20 0.38
POLB P06746 2/20 0.38
RAD52 P43351 2/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
GFER P55789 1/20 0.38
KCNA3 P22001 1/20 0.37
YES1 P07947 1/20 0.37
SRC P12931 1/20 0.37
PARP1 P09874 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4933388 0.96 KDM1A (0.49) KDM1AAGERTOP2AL3MBTL1TOP2B
SCHEMBL4938779 0.92 KDM1A (0.52) KDM1AL3MBTL1HTR1BPOLBRAD52
SCHEMBL4936777 0.90 KDM1A (0.46) KDM1AAGERTOP2AL3MBTL1TOP2B
SCHEMBL4934135 0.88 KDM1A (0.48) KDM1AAGERTOP2AL3MBTL1TOP2B
SCHEMBL4940719 0.88 KDM1A (0.55) KDM1AL3MBTL1POLBRAD52KMT2A
SCHEMBL4937730 0.83 KDM1A (0.41) KDM1AL3MBTL1HTR1BPOLBRAD52
SCHEMBL15101599 0.81 KDM1A (0.48) KDM1ATOP2ATOP2BPOLBRAD52
SCHEMBL4940783 0.81 TOP2A (0.57) KDM1ATOP2ATOP2BPOLBRAD52
Hydrochloric Acid SCHEMBL4912480 0.80 KDM1A (0.48) KDM1ATOP2ATOP2BPOLBRAD52
SCHEMBL14116114 0.80 KDM1A (0.41) KDM1AL3MBTL1HTR1BPOLBRAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080176889-A1 9-anilinoacridine alkylating agents ACADEMIA SINICA (TW) 2008-07-24 US disclosed
US-20080176889-A1 9-anilinoacridine alkylating agents ACADEMIA SINICA (TW) 2008-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176889-A1 9-anilinoacridine alkylating agents BCL9, MCL1, BCL9L KDM1A 1168/4885AGER 4336/4885TOP2A 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.